Cantú syndrome is caused by mutations in ABCC9

  • Bregje W M van Bon
  • Christian Gilissen
  • Dorothy K Grange
  • Raoul C M Hennekam
  • Hülya Kayserili
  • Hartmut Engels
  • Heiko Reutter
  • John R Ostergaard
  • Eva Morava
  • Konstantinos Tsiakas
  • Bertrand Isidor
  • Martine Le Merrer
  • Metin Eser
  • Nienke Wieskamp
  • Petra de Vries
  • Marloes Steehouwer
  • Joris A Veltman
  • Stephen P Robertson
  • Han G Brunner
  • Bert B A de Vries
  • Alexander Hoischen

Abstract

Cantú syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantú syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K(ATP) channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantú syndrome and suggest that this is a new member of the potassium channelopathies.

Bibliografische Daten

OriginalspracheEnglisch
DOIs
StatusVeröffentlicht - 08.06.2012
PubMed 22608503